Effects of Statins on Lipid Profile of Kidney Transplant Recipients: A Meta-Analysis of Randomized Controlled Trials

Table 1

Characteristics of the studies included in this meta-analysis.

First author’s name	Year	Country	Intervention	Time (months)	Dose (mg/d)	Number	Follow-up (months)	TC achieved (mmol±L)	LDL-C achieved (mmol±L)	HDL-C achieved; (mmol±L)	TG achieved (mmol±L)
Katznelson	1995	America	Pravastatin	4	20	24	24	5.2	2.79	1.45	1.34
Renders	2001	Germany	Atorvastatin	3	10	10	10	4.97	2.75	1.32	1.79
Hausberg	2001	Germany	Fluvastatin	6	40	18	18	6.19	3.57	1.86	1.84
Santos	2001	Brazil	Simvastatin	6	10	34	33	5.42	3.04	1.44	2.05
Kasiske	2001	America	Simvastatin	3	10	53	53	5.41	2.82	1.4	2.54
Holdaas	2001	Norway	Fluvastatin	3	40	182	122	5.47	3.06	1.4	2.04
Seron	2008	Spain	Fluvastatin	6	80	45	39	5.2	3.1	1.7	1.7
Yazbek	2015	Brazil	Pravastatin	12	10	61	51	4.16	2.26	1.17	1.77